Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin

Toxicology and Applied Pharmacology

Volumn 192, Issue 2, 2003, Pages 131-145

  Ray, Soma S ^a   Swanson, Hollie I ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Aryl hydrocarbon receptor; Differentiation; Dioxin; Keratinocytes; p14ARF; P16 INK4a; p53; Proliferation and senescence

Indexed keywords

BETA GALACTOSIDASE; DIOXIN; FILAGGRIN; INVOLUCRIN; PROTEIN P14; PROTEIN P16; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN;

CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KERATINOCYTE; POLLUTANT; SENESCENCE; TUMOR PROMOTION;

ANIMALIA;

EID: 0141682540     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00277-1     Document Type: Conference Paper

References (77)

1. Alani R.M., Hasskarl J., Grace M., Hernandez M.C., Israel M.A., Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. USA. 96:1999;9637-9641.
2. Alani R.M., Young A.Z., Shifflett C.B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA. 98:2001;7812-7816.
3. Almog N., Rotter V. Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta. 1333:1997;F1-F27.
4. Beebe L.E., Anver M.R., Riggs C.W., Fornwald L.W., Anderson L.M. Promotion of N-nitrosodimethylamine-initiated mouse lung tumors following single or multiple low dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 16:1995;1345-1349.
5. Campisi J. Cancer, aging and cellular senescence. In Vivo. 14:2000;183-188.
6. Dai C.Y., Enders G.H. p16 INK4a can initiate an autonomous senescence program. Oncogene. 19:2000;1613-1622.
7. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., Louis D.N., Li F.P., Rheinwald J.G. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:2000;1436-1447.
8. Dimri G.P., Itahana K., Acosta M., Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 20:2000;273-285.
9. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
10. Dong L., Ma Q., Whitlock J.P. Jr. Down-regulation of major histocompatibility complex Q1b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272:1997;29614-29619.
11. Eckert R.L., Crish J.F., Robinson N.A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77:1997;397-424.
12. Elferink C.J., Ge N.L., Levine A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol. Pharmacol. 59:2001;664-673.
13. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., Gonzalez F.J. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol. Pharmacol. 57:2000;1056-1063.
14. Esteller M. CpG hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 21:2002;5427-5440.
15. Esteller M., Cordon-Cardo C., Corn P.G., Meltzer S.J., Pohar K.S., Watkins D.N., Capella G., Peinado M.A., Matias-Guiu X., Prat J., Baylin S.B., Herman J.G. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res. 61:2001;2816-2821.
16. Evers B.M. Intestinal cell differentiation cellular mechanisms and the search for the perfect model focus on "involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation" Am. J. Physiol. 276:(6 Pt1):1999;C1243-C1244.
17. Eymin B., Leduc C., Coll J.L., Brambilla E., Gazzeri S. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene. 22:2003;1822-1835.
18. Fernandez-Salgeuro P.M., Ward J.M., Sundberg J.P., Gonzalez F.J. Lesions of aryl-hydrocarbon receptor deficient mice. Vet. Pathol. 34:1997;605-614.
19. Gaido K.W., Maness S.C. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 127:1994;199-208.
20. Ge N.L., Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J. Biol. Chem. 273:1998;22708-22713.
21. Greenlee W.F., Dold K.M., Osborne R. Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cell. Dev. Biol. 21:1985;509-512.
22. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340.
23. Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J., De Luca L.M. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis. 21:2000;1271-1279.
24. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:1996;859-867.
25. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:1996;56-64.
26. Harvat B.L., Wang A., Seth P., Jetten A.M. Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J. Cell. Sci. 111:(Pt 9):1998;1185-1196.
27. Hebert C.D., Cao Q.L., Birnbaum L.S. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells. Cancer Res. 50:1990;7190-7197.
28. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D., Baylin S.B. Interactivation of the CDKN2/p16MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530.
29. Hosoya T., Oda Y., Takahashi S., Morita M., Kawauchi S., Ema M., Yamamoto M., Fujii-Kuriyama Y. Defective development of secretory neurones in the hypothalamus of Arnt2-knockout mice. Genes Cells. 6:2001;361-374.
30. Hudson L.G., Toscano W.A. Jr., Greenlee W.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicol. Appl. Pharma. 82:1986;481-492.
31. Huschtscha L.I., Reddel R.R. p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis. 20:1999;921-926.
32. Itoshima T., Fujiwara T., Waku T., Shao J., Kataoka M., Yarbrough W.G., Liu T.J., Roth J.A., Tanaka N., Kodama M. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes involvement of p53 accumulation via ARF-mediated MDM2 down-regulation . Clin. Cancer Res. 6:2000;2851-2859.
33. Jin X., Nguyen D., Zhang W.W., Kyritsis A.P., Roth J.A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res. 55:1995;3250-3253.
34. Karlsson J.O., Ostwald K., Kabjorn C., Andersson M. A method for protein assay in Laemmli buffer. Anal. Biochem. 219:1994;144-146.
35. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
36. Kolluri S.K., Weiss C., Koff A., Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13:1999;1742-1753.
37. Lee G., Park B.S., Han S.E., Oh J.E., You Y.O., Baek J.H., Kim G.S., Min B.M. Concurrence of replicative senescence and elevated expression of p16(INK4A) with subculture-induced but not calcium-induced differentiation in normal human oral keratinocytes. Arch. Oral Biol. 45:2000;809-818.
38. Lee S.W., Fang L., Igarashi M., Ouchi T., Lu K.P., Aaronson S.A. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA. 97:2000;8302-8305.
39. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
40. Liggett W.H.J., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16:1998;1197-1206.
41. Loertscher J.A., Lin T.M., Peterson R.E., Allen-Hoffmann B.L. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol. Sci. 68:2002;465-472.
42. Loertscher J.A., Sattler C.A., Allen-Hoffmann B.L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol. Appl. Pharma. 175:2001;121-129.
43. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell. Biol. 12:2000;705-709.
44. Milstone L.M., LaVigne J.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. J. Invest. Dermatol. 82:1984;532-534.
45. Mitra J., Dai C.Y., Somasundaram K., El-Deiry W.S., Satyamoorthy K., Herlyn M., Enders G.H. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol. Cell. Biol. 19:1999;3916-3928.
46. Munro J., Stott F.J., Vousden K.H., Peters G., Parkinson E.K. Role of the alternative INK4A proteins in human keratinocyte senescence evidence for the specific inactivation of p16INK4A upon immortalization . Cancer Res. 59:1999;2516-2521.
47. Nickoloff B.J., Chaturvedi V., Bacon P., Qin J.Z., Denning M.F., Diaz M.O. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275:2000;27501-27504.
48. Ortega S., Malumbres M., Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:2002;73-87.
49. Panteleyev A.A., Thiel R., Wanner R., Zhang J., Roumak V.S., Paus R., Neubert D., Henz B.M., Rosenbach T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J. Invest. Dermatol. 108:1997;330-335.
50. Park S.H., Lee Y.S., Osawa Y., Hachiya M., Akashi M. Hsp25 regulates the expression of p21(Waf1/Cip1/Sdi1) through multiple mechanisms. J. Biochem. (Tokyo). 131:2002;869-875.
51. Pitot H.C., Goldsworthy T., Campbel H.A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40:1980;3616-3620.
52. Poland A., Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons examination of the mechanism of toxicity . Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
53. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 300:1982;271-273.
54. Pollenz R. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 141:2002;41.
55. Polsky D., Young A.Z., Busam K.J., Alani R.M. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 61:2001;6008-6011.
56. Puga A., Barnes S.J., Dalton T.P., Chang C.Y., Knudsen E.S., Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275:2000;2943-2950.
57. Rea M.A., Phillips M.A., Degraffenried L.A., Qin Q., Rice R.H. Modulation of human epidermal cell response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by epidermal growth factor. Carcinogenesis. 19:1998;479-483.
58. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., Sidransky D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56:1996;3630-3633.
59. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., D.e Luca, M., Catricala C., O'Toole K.M. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:2002;5157-5172.
60. Rice R.H., Cline P.R. Opposing effects of 2,3,7,8-teraclorodibenzo-p-dioxin and hydrocortisone on growth and differentiation of cultured malignant human keratinocytes. Carcinogenesis. 5:1984;367-371.
61. Schmidt J.V., Bradfield C.A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:1996;55-89.
62. Scott R.E. Differentiation, differentiation/gene therapy and cancer. Pharmacol. Ther. 73:1997;51-65.
63. Sgambato A., Cittadini A., Faraglia B., Weinstein I.B. Multiple functions of p27(Kip1) and its alterations in tumor cells a review . J. Cell Physiol. 183:2000;18-27.
64. Sherr C.J., Roberts J.M. CDK inhibitors positive and negative regulators of G1-phase progression . Genes Dev. 13:1999;1501-1512.
65. Song Z., Pollenz R.S. Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Mol. Pharmacol. 62:2002;806-816.
66. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H., Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
67. Suskind R.R. Chloracne, "the hallmark of dioxin intoxication" Scand J. Work Environ. Health. 11:(3 Spec No.):1985;165-171.
68. Swanson H.I., Chan W.K., Bradfield C.A. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270:1995;26292-26302.
69. Vousden K.H. p53 death star . Cell. 103:2000;691-694.
70. Weber H.O., Samuel T., Rauch P., Funk J.O. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Oncogene. 21:2002;3207-3212.
71. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21:2001;6748-6757.
72. Weil M., Raff M.C., Braga V.M. Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr. Biol. 9:1999;361-364.
73. Whitlock J.P.J. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125.
74. Yao E.F., Denison M.S. DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer. Biochemistry. 31:1992;5060-5067.
75. Yuspa S.H. The pathogenesis of squamous cell cancer lessons learned from studies of skin carcinogenesis - thirty-third G. H. A. Clowes Memorial Award Lecture . Cancer Res. 54:1994;1178-1189.
76. Zhang H., Pan K.H., Cohen S.N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomalloci. Proc. Natl. Acad. Sci. USA. 100:2003;3251-3256.
77. Zhu D., Xu G., Ghandhi S., Hubbard K. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins implications for cellular senescence . J. Cell Physiol. 193:2002;19-25.